Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Hilton Baltimore Inner Harbor

Apr 05, 2027 8:00 AM - Apr 07, 2027 12:30 PM

401 W Pratt Street, Baltimore, MD 21201, USA

Global Pharmacovigilance and Risk Management Strategies Conference

Early Bird Rate Ends

DAYS

HOURS

MINUTES

SECONDS

Session 5: Lessons from Post-Market Surveillance on How to Bridge Safety, Quality, and Device Risk

Session Chair(s)

Ranjeeta  Sinvhal, MD

Ranjeeta Sinvhal, MD

Executive Medical Director, Medical Safety, AbbVie, United States

Combination drug-device products sit at the intersection of safety, quality, and device risk management, and post-market surveillance is where those disciplines either work together or work in silos. This session examines how safety and quality functions partner in practice: applying ICH Q9 principles to prospective Quality Risk Management, using adverse event data to inform continued process verification and signal detection, and supporting ad hoc or for-cause Health Risk Assessments and product recalls. Speakers will also address drug-device combination product surveillance specifically, including how post-market safety data shapes target product profiles and device development, how medication error data collection and term selection inform device design and user instructions, and how organizations decide between device risk management and Health Risk Assessment escalation pathways. The session will include case examples throughout and may reference the MedDRA Points to Consider Companion Document Section 5 on manufacturing and quality system issues, with perspectives from MedDRA MSSO, industry, and FDA.

Learning Objective :

At the conclusion of this session, participants should be able to:

  • Use post-market safety data, including medication errors and adverse event trends, to guide device design.
  • Decide when a safety issue needs device risk management versus a formal Health Risk Assessment.
  • Apply ICH Q9 principles to signal detection and continued process verification.

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.